Evidence map›Paper›PMID 32922480›Full record

ArticleIranian journal of pharmaceutical research : IJPR2020

Saeed Dezianian, Jamil Zargan, Hamid Reza Goudarzi, Ashkan Haji Noormohamadi, Mohsen Mousavi, Hani Keshavarz Alikhani, Behrooz Johari

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of pharmaceutical research : IJPR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Evaluation of the Cytotoxic Effects ofJournal of arthropod-borne diseases · 2026
    Article
  2. Characterization ofToxins · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Saeed DezianianDepartment of Biology, Faculty of Basic Science, Imam Hossein University, Tehran, Iran.
Jamil ZarganDepartment of Biology, Faculty of Basic Science, Imam Hossein University, Tehran, Iran.
Hamid Reza GoudarziDepartment of Venomous Animals and Antivenin Production, Razi Vaccine and Serum Research Institute, Karaj, Iran.
Ashkan Haji NoormohamadiDepartment of Biology, Faculty of Basic Science, Imam Hossein University, Tehran, Iran.
Mohsen MousaviDepartment of Biology, Faculty of Basic Science, Imam Hossein University, Tehran, Iran.
Hani Keshavarz AlikhaniDepartment of Biology, Faculty of Basic Sciences, Razi University, Kermanshah, Iran.
Behrooz JohariDepartment of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Imam Hossein University · IRRazi University · IRRazi Vaccine and Serum Research Institute · IRZanjan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scorpion venoms contain potentially useful pharmacological agents. Several studies demonstrate that the venoms of some scorpions induce apoptosis and inhibit the growth of cancer cells; therefore, they have been investigated for isolating anticancer components. In this study, antitumor effects of

Indexed as

Anti-cancer drugCancer therapyHottentotta schachScorpion crude venom

Identifiers

PMID32922480
PMCPMC7462501
OpenAlexW3007790583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.